ISZO CAPITAL LP Q4 2013 significant ownership

ISZO CAPITAL LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

ISZO CAPITAL LP Q4 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Somaxon Pharmaceuticals, Inc.	February 14, 2013	302,686	4.2%
BIOLASE TECHNOLOGY INC^{Sold out}	February 14, 2012	0	0.0%
AP PHARMA INC /DE/	July 11, 2011	18,500,001	9.0%
CPEX Pharmaceuticals, Inc.	February 14, 2011	38,756	1.5%

Compare quarters

Export ISZO CAPITAL LP's holdings